Assessment of Chemotherapy Response in Ewing Sarcoma

被引:3
|
作者
McCarville, M. Beth [1 ]
Federico, Sara M. [2 ]
Bishop, Michael W. [2 ]
Pappo, Alberto S. [2 ]
Shulkin, Barry L. [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Diagnost Imaging, 262 Danny Thomas Pl, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Oncol, 262 Danny Thomas Pl, Memphis, TN 38105 USA
关键词
D O I
10.1148/radiol.2016160903
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:647 / 648
页数:3
相关论文
共 50 条
  • [21] Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival
    Koshkin, Vadim S.
    Bolejack, Vanessa
    Schwartz, Lawrence H.
    Wahl, Richard L.
    Chugh, Rashmi
    Reinke, Denise K.
    Zhao, Binsheng
    O, Joo H.
    Patel, Shreyaskumar R.
    Schuetze, Scott M.
    Baker, Laurence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (30) : 3680 - +
  • [22] Treatment of Ewing Sarcoma with Concurrent Radiotherapy and Chemotherapy
    Heikamp, Emily
    JOURNAL OF PEDIATRICS, 2018, 199 : 193 - 193
  • [23] EWING SARCOMA, ADJUVANT CHEMOTHERAPY AND PATHOLOGIC FRACTURE
    ROSENSTOCK, JG
    JONES, PM
    PEARSON, D
    PALMER, MK
    EUROPEAN JOURNAL OF CANCER, 1978, 14 (07) : 799 - 803
  • [24] RESPONSE TO CHEMOTHERAPY ESTIMATED BY FDG PET AS AN IMPORTANT PROGNOSTIC FACTOR IN PATIENTS WITH EWING SARCOMA
    Raciborska, A.
    Bilska, K.
    Drabko, K.
    Chaber, R.
    Pogorzala, M.
    Polczynska, K.
    Sobol, G.
    Wieczorek, M.
    Muszynska-Roslan, K.
    Dziuk, M.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S178 - S178
  • [25] Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma
    Raciborska, A.
    Bilska, K.
    Drabko, K.
    Michalak, E.
    Chaber, R.
    Pogorzala, M.
    Polczynska, K.
    Sobol, G.
    Wieczorek, M.
    Muszynska-Roslan, K.
    Rychlowska-Pruszynska, M.
    Rodriguez-Galindo, C.
    Dziuk, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (02): : 189 - 195
  • [26] Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma
    A. Raciborska
    K. Bilska
    K. Drabko
    E. Michalak
    R. Chaber
    M. Pogorzała
    K. Połczyńska
    G. Sobol
    M. Wieczorek
    K. Muszyńska-Rosłan
    M. Rychlowska-Pruszyńska
    C. Rodriguez-Galindo
    M. Dziuk
    Clinical and Translational Oncology, 2016, 18 : 189 - 195
  • [27] Utility of Histologic and Radio logic Response to Induction Chemotherapy in Patients With Ewing Sarcoma (EWS)
    Pan, H.
    Morani, A.
    Wang, W.
    Hess, K. R.
    Lin, P. P.
    Daw, N. C.
    Mahajan, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S116 - S116
  • [28] Response of refractory Ewing sarcoma to pazopanib
    Alcindor, Thierry
    ACTA ONCOLOGICA, 2015, 54 (07) : 1063 - U184
  • [29] Volumetric FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in paediatric patients with Ewing sarcoma and osteosarcoma
    Bailly, C.
    Campion, L.
    Thebaud, E.
    Corradini, N.
    Moreau, A.
    Dansette, D.
    Bodere, F. Kraeber
    Carlier, T.
    Milin, C. Bodet
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S257 - S257
  • [30] Use of FDG PET in Staging, Restaging, and Assessment of Therapy Response in Ewing Sarcoma
    Bestic, Joseph M.
    Peterson, Jeffrey J.
    Bancroft, Laura W.
    RADIOGRAPHICS, 2009, 29 (05) : 1487 - U331